SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 655.57 |
| Enterprise Value ($M) | 499.25 |
| Book Value ($M) | 1,056.08 |
| Book Value / Share | 3.54 |
| Price / Book | 0.62 |
| NCAV ($M) | 446.90 |
| NCAV / Share | 1.50 |
| Price / NCAV | 1.47 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.15 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.81 |
| Current Ratio | 9.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 751.37 |
| Assets | 1,360.55 |
| Liabilities | 304.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 28.83 |
| Operating Income | -282.77 |
| Net Income | -162.86 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -108.56 |
| Cash from Investing | 121.41 |
| Cash from Financing | 12.77 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 9.30 | 20.15 | |
| 13G/A | Baillie Gifford & Co | 4.40 | -46.37 | |
| 13G/A | Hansen Carl L. G. | 20.60 | 2.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,019,487 | 5,966,282 | 33.85 | |
| 1,904,422 | 5,444,589 | 34.98 | |
| 1,602,342 | 4,176,889 | 38.36 | |
| 1,703,161 | 4,470,735 | 38.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABOS – Acumen Pharmaceuticals, Inc. | ABUS – Arbutus Biopharma Corporation |